SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Corcept Therapeutics Incorporated (CORT)
CORT 72.91-0.8%12:58 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: mopgcw4/8/2007 5:32:51 AM
   of 32
 
Corcept Completes Private Placement
Monday April 2, 12:42 pm ET
Corcept Therapeutics Completes Private Offering of Common Stock

NEW YORK (AP) -- Pharmaceutical company Corcept Therapeutics Inc. said Monday it completed the private placement of 9 million shares of common stock for $1 per share.
The investors were led by Paperboy Ventures LLC, Sutter Hill Ventures, Alta Partners LLP, venture capital firms and members of Corcept's board of directors.

The company said it will use the proceeds to fund clinical trials, including preparing for the next Phase III study on Corlux, an experimental treatment for psychotic major depression.

Shares of Corcept rose 17 cents, or 19 percent, to $1.07 on the Nasdaq Stock Market in midday trading.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext